News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Can Eli Lilly and Company (LLY) Win Any Important Patent Lawsuit?


8/22/2010 12:04:24 PM

Pharmalot -- Already one of the most vulnerable big drugmakers to patent expirations, Eli Lilly was dealt a serious blow late yesterday when a federal judge invalidated a method-of-use patent on its Strattera ADHD pill. The upshot means that a slew of generic pills from Teva Pharmaceutical and Sandoz, among others, are now expected to appear imminently, instead of in 2017.

Read at Pharmalot


comments powered by Disqus
Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES